CCaTS: Accelerating discoveries toward better health
Mayo Clinic Center for Clinical and Translational Science (CCaTS) is funded by the National Institutes of Health (NIH) Clinical and Translational Science Awards (CTSA) program, grant numbers UL1TR002377, KL2TR0002379 and TL1TR002380 from the National Center for Advancing Translational Sciences (NCATS).
CCaTS is a central hub for institutional advancement of research and education at Mayo Clinic. The center provides tools and expert consultation to support every aspect of medical research, including basic discovery science, clinical and community-engaged research, and late-stage application and commercialization. As a member of the national CTSA program, CCaTS joins a national network of medical research institutions collaborating to transform how clinical and translational research is conducted nationwide.
Mayo Clinic CCaTS is led by Sundeep Khosla, M.D., principal investigator and director of CCaTS, and dean for clinical and translational science at Mayo Clinic. David O. Warner, M.D., is co-principal investigator and associate director of CCaTS, and is also principal investigator of the KL2 mentored career development grant. Anthony J. Windebank, M.D., is principal investigator of the TL1 predoctoral training grant.
The content of this website is solely the responsibility of Mayo Clinic CCaTS and does not necessarily represent the official views of the NIH.
News
Precision Genomics Point the Way to Mutations Associated With Accelerated Aging
"We're using precision genomics like a heat-seeking missile," says Mrinal S. Patnaik, M.B.B.S., a Mayo Clinic hematologist and clinical researcher. "Not to destroy, but to zero in on genetic mutations that may be linked with short telomere and other inherited bone marrow failure syndromes, providing unique insights into their disease biology."
Read more on the Mayo Clinic News Network.
After Grant Renewal, CCaTS Abuzz With Activity
In October 2017, the NIH renewed Mayo Clinic Clinical and Translational Science Award from the National Center for Advancing Translational Sciences — an award totaling $48.8 million over five years. This renewal allows Mayo Clinic to continue pursuing its long-term goals in clinical and translational science, while also setting new short-term objectives.
Read more on Mayo's Advancing the Science blog.
CCaTS Director Receives Frontiers in Science Award
Dr. Khosla has received the 2018 American Association of Clinical Endocrinologists Frontiers in Science Award. This award recognizes his contributions to the field of endocrinology. Dr. Khosla is the director of Mayo Clinic CCaTS and is the chair of research for Mayo's Division of Endocrinology, Diabetes, Metabolism and Nutrition.
Read more on Mayo Clinic News Network.
Are we breathing wrong?
A Mayo Clinic researcher's observations about animals adapted to live at high altitudes, such as llamas and bar-headed geese, may soon lead to a better understanding of how to help patients with blood disorders. Says Michael J. Joyner, M.D., "Hopefully we'll make some discoveries about oxygen transport in humans that will be of general interest to the whole field and that may provide insights into patient care."
Read more on Mayo's Advancing the Science blog.
Reeling in the next big medical innovation
Inspired by the show "Shark Tank," last summer Mayo Clinic hosted the Walleye Tank — an event designed to educate, empower and support entrepreneurs at Mayo Clinic and from throughout the state of Minnesota. "Anglers" pitched their ideas and winners were selected. "Every researcher is an entrepreneur," says Xavier Frigola, Ph.D., coordinator of the Mayo Clinic Business Accelerator.
Read more from Discovery's Edge magazine.